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OPINION
Mosquitoes Reset Malaria Parasites
Philip J. Spence1*, Thibaut Brugat2, Jean Langhorne2*
1 Institute of Immunology and Infection Research, and Centre for Immunity, Infection and Evolution,
University of Edinburgh, Edinburgh, United Kingdom, 2 Francis Crick Institute, Mill Hill Laboratory, London,
United Kingdom
* Philip.Spence@ed.ac.uk (PJS); Jean.Langhorne@crick.ac.uk (JL)
Serial blood passage of Plasmodium universally increases parasite virulence, which can be
reversed by mosquito transmission. How mosquitoes reset Plasmodium virulence has been
unknown. We have shown that mosquito transmission modifies expression of Plasmodium
subtelomeric multigene families, including those that code for variant surface antigens (VSA),
and transforms the systemic immune response to blood-stage infection. In this way, the mos-
quito regulates malaria disease severity. Here, we present a model in which expression of multi-
gene families is reset by epigenetic reprogramming of Plasmodium within the mosquito. This
prepares the malaria parasite for entry into a new unknown host and transforms the early para-
site–host interactions that shape disease severity. Studying the molecular mechanisms that
operate outside the human host to regulate Plasmodium virulence is therefore a priority.
Historical Perspective
It has been recognised for decades that serial blood passage of Plasmodium through rodents,
primates, or humans universally increases parasite virulence. In 1917, induced malaria was first
used as pyretic therapy for neurosyphilis, with Plasmodium vivax routinely inoculated to elicit
a mild form of disease. Yet passage through the human host elevated parasitaemia and exacer-
bated disease, increasing the requirement for chemotherapeutic intervention [1]. Blood passage
of Plasmodium knowlesi or Plasmodium cynomolgi, whether through human volunteers or
nonhuman primates, similarly elevated parasite densities and disease severity [2–4]. And serial
blood passage of every rodent malaria parasite species increased parasitaemia and pathogenic-
ity [5–8]. On the other hand, it has been assumed for decades that mosquito transmission
resets Plasmodium virulence [8]. At the Horton Mental Hospital, a pioneering centre for
malaria therapy, Plasmodium strains were maintained by mosquito transmission to preserve
their clinical and parasitological features [9]. Nevertheless, direct evidence that mosquito trans-
mission resets Plasmodium virulence, and a mechanism to explain this phenomenon, have
been missing [6,10,11].
Mosquito Transmission Resets Plasmodium Virulence
We have recently shown that mosquito transmission modifies gene expression in blood-stage
malaria parasites and in this way resets Plasmodium virulence [12]. Whereas serial blood pas-
sage of Plasmodium chabaudi leads to hyperparasitaemia and severe disease in laboratory
mice, mosquito transmission of serially blood-passaged parasites leads to a low-grade, chronic,
recrudescing infection with minimal pathology. Attenuation of virulence is not parasite clone-
or dose-dependent and therefore cannot be explained by bottlenecking during mosquito trans-
mission [13]. Instead, attenuation of the blood-stage parasite is dependent upon host genotype
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[14] and an intact host immune response [12] and associates with increased expression of Plas-
modium subtelomeric multigene families, including those that code for VSA (Box 1). Mosquito
transmission therefore modifies expression of parasite virulence genes and transforms host
immunity in the pathogenic blood-stage of infection. As such, the mosquito vector both trans-
mits malaria and regulates disease severity.
Epigenetic Reprogramming of Plasmodium
By recognising this key function of the mosquito, new research avenues open that can acceler-
ate our understanding of the pathogenesis of human malaria. It is first important to delineate
where, when, and how mosquito transmission modifies expression of Plasmodium virulence
genes. This is likely to be a consequence, at least in part, of necessary changes in gene expres-
sion for progression through each step of the life cycle in both vector and host [15]. However,
epigenetic reprogramming [16] of Plasmodium provides a mechanism by which expression of
virulence genes could be reset within the vector. Heritable chromatin modifications control
transcription of subtelomeric multigene families in the blood-stage parasite [15] and can thus
promote adaptation of malaria parasites to their host [17]. Nevertheless, global erasure of epi-
genetic marks following gamete fusion in the mosquito could reset expression of multigene
families and thus prepare Plasmodium for entry into a new unknown host (Fig 1).
Resetting Plasmodium gene expression could be particularly important when transmission
is seasonal, and parasites undergo an extended period of host adaptation in a chronically
infected individual before their return to the mosquito. In this context, it is important to know
whether parasite virulence increases in the chronic phase of infection, as has been observed in
human volunteers [3]. Thus, serial blood passage per se may not increase Plasmodium viru-
lence; an alternative explanation is that virulence increases with time elapsed from the mos-
quito. This will be observed only in a new host and when mosquito transmission is bypassed.
Immune Control of Plasmodium Virulence
By resetting Plasmodium gene expression, the mosquito can also control how blood-stage para-
sites elicit the systemic immune response in a new host. Mosquito transmission attenuates P.
chabaudi virulence because merozoites that emerge from the liver induce an immune response
that can rapidly control parasite growth without collateral damage [12]. This contrasts with the
host response to serially blood-passaged parasites that causes severe immunopathology. Does
Box 1. Mosquito Transmission Modifies Expression of Plasmodium
Virulence Genes in Human Malaria
Transcriptional profiling [21] and proteomic analysis [22] of cultured Plasmodium fal-
ciparum demonstrates that the diversity and magnitude of rifin and var gene expression
is increased in sporozoites (isolated from mosquito salivary glands) as compared to mer-
ozoites, trophozoites, or gametocytes. Furthermore, 53 of 59 var genes were transcribed
in a single human volunteer infected with P. falciparum by mosquito bite just five days
after merozoite egress from the liver [23], and diversity of var gene expression has been
shown to decrease in human volunteers after blood passage [24]. Collectively, these data
support a model in which expression of Plasmodium subtelomeric multigene families is
increased as parasites transit through the mosquito and subsequently decreases with
time elapsed from the vector.
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increasing expression of Plasmodium VSA explain how the mosquito can transform the elicited
host immune response? Or does mosquito transmission change the context in which blood-
stage parasites initiate host immunity (e.g., by modifying invasion, cytoadherence, or seques-
tration)? Furthermore, it remains possible that immune priming and/or regulation during the
pre-erythrocytic stages of infection can subsequently modify the systemic immune response to
the blood-stage parasite. In all scenarios, the early immune response, elicited in the context of a
mosquito bite, can shape malaria disease severity. In turn, the developing immune response is
likely to influence expression of Plasmodium virulence genes and could therefore also directly
regulate parasite pathogenicity.
Improving Models of Malaria
Mosquitoes reset malaria parasites and can be used to strengthen the relevance of mouse mod-
els to human malaria. We should therefore aim to initiate experimental infections by the natu-
ral route of transmission wherever possible. We should also strive to study combinations of
vector, parasite, and host that exist in nature to validate or improve our current experimental
systems. Mouse models are important for interrogating the pathogenesis of malaria because
they can answer research questions that cannot be addressed directly in humans. Moreover,
relevant mouse models can act as a bridge between human studies. For example, vector regula-
tion of Plasmodium virulence was first observed in human volunteers and subsequently repro-
duced and delineated in mice; the molecular mechanisms that operate within the mosquito to
regulate Plasmodium virulence can now be dissected with human malaria parasites.
To this end, inoculation of human volunteers with Plasmodium is a powerful experimental
model [18,19]. In this setting, it is possible to look for evidence of epigenetic reprogramming of
P. vivax in laboratory-reared anopheline mosquitoes fed on infected volunteers. Interrogating
Fig 1. Epigenetic reprogramming of Plasmodiumwithin the mosquito.Reset: expression of subtelomeric multigene families is reset in the mosquito by
epigenetic reprogramming of the zygote. This ensures that a parasite population will always express all multigene family members from the start of the
erythrocytic cycle and gives merozoites the best possible chance of establishing a blood-stage infection every time they emerge from the liver (e.g., it may be
beneficial to express all VSA upon liver egress, as a malaria-experienced host will have pre-existing antibodies that recognise a broad repertoire of variant
antigens [23]). Select and switch: parasites that express (or switch to) multigene family members offering a survival advantage in their new host are retained,
whereas parasites that silence these genes are lost through rounds of selection. In time, this leads to a parasite population expressing a narrow repertoire of
multigene family members that promotes survival and chronicity. The further into the chronic phase of infection, the better adapted are parasites to their host.
Plasmodium virulence therefore increases, and the need to reset gene expression also increases. Reset: in preparation for entry into the next host, all
chromatin marks are again erased following gamete fusion. This model of gene expression provides a general mechanism by which all Plasmodium
subtelomeric multigene families could be regulated by the mosquito.
doi:10.1371/journal.ppat.1004987.g001
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expression and regulation of subtelomeric multigene families in gametocytes as they circulate,
transmit, and then pass through each developmental checkpoint of sporogony is a priority. So,
too, is examining how route of transmission influences the systemic host response to blood-
stage infection. For this, the immune response to P. falciparum can be compared in peripheral
blood obtained from human volunteers infected via mosquito bite versus direct inoculation of
blood-stage parasites (isolated just 6–8 days after liver egress [20]). Nevertheless, mice are
absolutely required to observe the interactions between parasites and the immune system that
shape disease severity because these interactions occur in tissues, such as spleen. We should
therefore aim to identify mouse models that share a common immune signature of infection in
whole blood with human malaria and use these models to delineate the immune response to
Plasmodium in relevant tissues.
Concluding Remarks
Amosquito is not simply a flying syringe. Mosquitoes reset malaria parasites in preparation for
entry into a new unknown host and thereby regulate Plasmodium virulence. Furthermore, they
are a mixing pot for the generation of new recombinant parasites and can thus transmit previ-
ously unseen virulent strains. By studying events within the mosquito, we will accelerate our
understanding of malaria disease severity.
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